Europe Primary Care Poc Diagnostics Market Size & Outlook
Related Markets
Europe primary care poc diagnostics market highlights
- The Europe primary care poc diagnostics market generated a revenue of USD 324.1 million in 2024.
- The market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating product in 2024.
- Cancer Marker is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 324.1 million |
| Market revenue in 2030 | USD 439.4 million |
| Growth rate | 4.8% (CAGR from 2025 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Cancer Marker |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose Testing, Hb1Ac Testing, Coagulation, Fertility/Pregnancy, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Autoimmune Disease, Urinalysis/Nephrology |
| Key market players worldwide | Roche Holding AG ADR, BD, Danaher Corp, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Johnson & Johnson Services, Inc., Becton Dickinson & Co, OraSure Technologies Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.7% of the global primary care poc diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 323.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Primary Care POC Diagnostics Market Scope
Primary Care POC Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | https://www.orasure.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Europe primary care poc diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary care poc diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 30.76% in 2024. Horizon Databook has segmented the Europe primary care poc diagnostics market based on glucose testing, hb1ac testing, coagulation, fertility/pregnancy, infectious diseases, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug abuse testing, autoimmune disease, urinalysis/nephrology covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing demand for rapid diagnostic procedures coupled with rising prevalence of chronic diseases in the region are some key drivers of this market. Furthermore, government contracts contributing towards the development of point of care diagnostics equipment are expected to fuel future market growth.
For example, in May 2014, the European Space Agency (ESA) funded Radissons Diagnostics for the development of an innovative blood testing device for astronauts. Presence of favorable government initiatives and the development of independent diagnostic centers are further expected to boost the growth of the market over the forecast period.
Reasons to subscribe to Europe primary care poc diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe primary care poc diagnostics market databook
-
Our clientele includes a mix of primary care poc diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe primary care poc diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe primary care poc diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe primary care poc diagnostics market size, by country, 2018-2030 (US$M)
Europe Primary Care POC Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
